journal article·2011-09-07

Fast Dissolving Curcumin Cocrystals

Palash Sanphui, N. Rajesh Goud, U. B. Rao Khandavilli, Ashwini Nangia

Crystal Growth & Design· Volume 11· Issue 9
Publisher page

Abstract

Curcumin is the principal curcuminoid of the popular Indian spice turmeric. Despite the diverse pharmacological activities of this bioactive phenol, its application as a drug is severely limited by poor aqueous solubility. We report novel cocrystals of curcumin ( 1 ) with resorcinol and pyrogallol obtained by liquid-assisted grinding. Curcumin–resorcinol ( 1a ) (1:1) and curcumin–pyrogallol ( 1b ) (1:1) were characterized by X-ray diffraction, thermal analysis, FT-IR, FT-Raman, and solid-state 13 C NMR spectroscopy. The 1:1 cocrystal stoichiometry is sustained by O–H···O hydrogen bonds between the phenolic OH groups of the coformers to the carbonyl group of curcumin. The melting point of the cocrystals is in between that of curcumin and the coformer and the lower melting cocrystal 1b is more soluble than higher melting 1a . The dissolution rates of curcumin–resorcinol ( 1a ) and curcumin–pyrogallol ( 1b ) in 40% EtOH–water are ∼5 and ∼12 times faster than that for curcumin.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Crystallography and molecular interactions · Curcumin's Biomedical Applications · Crystallization and Solubility Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Chemistry and ‡Technology Business Incubator, University of Hyderabad, Prof. C. R. Rao Road, Gachibowli, Central University P.O., Hyderabad 500046, AP, India

References (62)

Show source-provided references
1. Kola I. · Nat. Rev. Drug Discovery · 2004 · 3 · 71110.1038/nrd1470 ↗
2. Stahly G. P. · Cryst. Growth Des. · 2009 · 9 · 421210.1021/cg900873t ↗
3. Vishweshwar P. · J. Pharm. Sci. · 2006 · 95 · 49910.1002/jps.20578 ↗
4. US Food and Drug administration approved GRAS list. EAFUS: A food additive database.http://www.cfsan.fda.gov/_dms/ eafus.html.
5. Remenar J. F. · J. Am. Chem. Soc. · 2003 · 125 · 845610.1021/ja035776p ↗
6. Babu N. J. · Cryst. Growth Des. · 2011 · 11 · 266210.1021/cg200492w ↗
7. Amidon G. L. · Pharm. Res. · 1995 · 12 · 41310.1023/A:1016212804288 ↗
8. Çıkrıkçı S. · Rec. Nat. Prod. · 2008 · 2 · 19
9. Hatcher H. · Cell. Mol. Life Sci. · 2008 · 65 · 163110.1007/s00018-008-7452-4 ↗
10. Mahady G. B. · Anticancer Res. · 2002 · 22 · 4179
11. Sugiyama Y. · Biochem. Pharmacol. · 1996 · 52 · 51910.1016/0006-2952(96)00302-4 ↗
12. Ruby A. J. · Cancer Lett. · 1995 · 94 · 7910.1016/0304-3835(95)03827-J ↗
13. Jordan W. C. · J. Natl. Med. Assoc. · 1996 · 88 · 333
14. Qureshi S. · Planta Med. · 1992 · 58 · 12410.1055/s-2006-961412 ↗
15. Lao C. D. · BMC Complement, Altern. Med. · 2006 · 6 · 1010.1186/1472-6882-6-10 ↗
16. Anand P. · Mol. Pharmaceutics · 2007 · 4 · 80710.1021/mp700113r ↗
17. Wang Y. J. · J. Pharm. Biomed. Anal. · 1997 · 15 · 186710.1016/S0731-7085(96)02024-9 ↗
18. Antony B. · J. Pharm. Sci. · 2008 · 445
19. Zhang F. · J. Pharm. Sci. · 2011 · 100 · 277810.1002/jps.22512 ↗
20. Gupta N. K. · J. Pharm. Sci. · 2011 · 100 · 198710.1002/jps.22393 ↗
21. Schultheiss N. · CrystEngComm · 2010 · 12 · 243610.1039/c002045a ↗
22. Karki S. · CrystEngComm · 2010 · 12 · 403810.1039/c0ce00428f ↗
23. Bethune S. J. · Cryst. Growth Des. · 2011 · 11 · 281710.1021/cg1016092 ↗
24. Schultheiss N. · Cryst. Growth Des. · 2009 · 9 · 295010.1021/cg900129f ↗
25. McNamara D. P. · Pharm. Res. · 2006 · 23 · 188810.1007/s11095-006-9032-3 ↗
26. Sanphui P. · Chem. Commun. · 2011 · 47 · 501310.1039/c1cc10204d ↗
27. Mukherjee A. · Cryst. Growth Des. · 2011 · 11 · 263710.1021/cg200361x ↗
28. Yang C. J. · Lung Cancer · 2009 · 66 · 16210.1016/j.lungcan.2009.01.016 ↗
29. Tang G. · J. Med. Chem. · 2007 · 50 · 172310.1021/jm061400l ↗
30. Trask A. V. · Chem. Commun. · 2004 · 89010.1039/b400978a ↗
31. Balasubramanian K. · J. Agric. Food Chem. · 2006 · 54 · 351210.1021/jf0603533 ↗
32. Parimita S. P. · Acta Crystallogr. · 2007 · 63 · o860
33. Bernstein J. · Angew. Chem., Int. Ed. Engl. · 1995 · 34 · 155510.1002/anie.199515551 ↗
34. Cambridge Structural Database, Ver. 5.32, May 2011 update, Cambridge Crystallographic Data Center, UK;www.ccdc.cam.ac.uk.
35. Ermer O. · Angew. Chem., Int. Ed. Engl. · 1994 · 33 · 175510.1002/anie.199417551 ↗
36. Dinger M. B. · Eur. J. Org. Chem. · 2000 · 246710.1002/1099-0690(200007)2000:13<2467::AID-EJOC2467>3.0.CO;2-N ↗
37. Parvez M. · Acta Crystallogr. · 1990 · 46 · 16510.1107/S0108767389011141 ↗
38. Andresen T. L. · Chem. Mater. · 2000 · 12 · 242810.1021/cm0003020 ↗
39. Ma Z. · Mol. Pharmaceutics · 2007 · 4 · 37310.1021/mp070013k ↗
40. Aitipamula S. · CrystEngComm · 2009 · 11 · 182310.1039/B904616J ↗
41. Bhatt P. M. · Cryst. Growth Des. · 2009 · 9 · 95110.1021/cg8007359 ↗
42. Stanton M. K. · Cryst. Growth Des. · 2009 · 9 · 134410.1021/cg8005019 ↗
43. Thakuria R. · CrystEngComm. · 2011 · 13 · 175910.1039/c0ce00787k ↗
44. Remenar J. F. · Mol. Pharmaceutics · 2007 · 4 · 38610.1021/mp0700108 ↗
45. Li J. · Chem. Commun. · 2011 · 47 · 153010.1039/C0CC04117C ↗
46. Elbagerma M. A. · Cryst. Growth Des. · 2010 · 10 · 236010.1021/cg100156a ↗
47. Tishmack P. A. · J. Pharm. Sci. · 2002 · 92 · 44110.1002/jps.10307 ↗
48. Vogt F. G. · Cryst. Growth Des. · 2009 · 9 · 92110.1021/cg8007014 ↗
49. Fagerberg J. H. · Mol. Pharmaceutics · 2010 · 7 · 141910.1021/mp100049m ↗
50. Otsuka M. · Chem. Pharm. Bull. · 1991 · 39 · 266710.1248/cpb.39.2667 ↗
51. Pudipeddi M. · J. Pharm. Sci. · 2005 · 94 · 92910.1002/jps.20302 ↗
52. Hancock B. C. · Pharm. Res. · 2000 · 17 · 39710.1023/A:1007516718048 ↗
53. Murashima T. · Tetrahedron Lett. · 2005 · 46 · 11310.1016/j.tetlet.2004.11.024 ↗
54. 2008
55. Dolomanov O. V. · J. Appl. Crystallogr. · 2009 · 42 · 33910.1107/S0021889808042726 ↗
56. 2000
57. Spek A. L. · 2002
58. Spek A. L. · J. Appl. Crystallogr. · 2003 · 36 · 710.1107/S0021889802022112 ↗
59. Barbour L. J. · 1999
60. Kraus N. · 2000
61. Glomme A. · J. Pharm. Sci. · 2005 · 94 · 110.1002/jps.20212 ↗
62. Viscomi G. C. · CrystEngComm · 2008 · 10 · 107410.1039/b717887e ↗